Lowers 2022 Adjusted EBITDA view to $203M-$208M from $208M-$218M. Raises 2022 CapEx view to $100M-$105M from $90M-$95M.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on RDNT:
- RadNet Acquires a Controlling Interest in Heart & Lung Imaging Limited, a London-Based Teleradiology Network Focused on Lung Cancer Screening
- RadNet acquires controlling interest in U.K.’s Heart & Lung Imaging
- RadNet, Inc. Announces Date of its Third Quarter 2022 Financial Results Conference Call
- RadNet’s NJIN acquires radiology assets of Montclair Radiology
- RadNet’s Joint Venture, New Jersey Imaging Network, Acquires the Imaging Operations of Montclair Radiology, Expanding its Presence in New Jersey